The US Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adu...
ASCEND Therapeutics Competitors or Alternatives
ASCEND Therapeutics's top competitors include rEVO Biologics, Duchesnay Inc. and Carwin Pharmaceutical Associates.
ASCEND Therapeutics VS rEVO Biologics
rEVO Biologics is seen as one of ASCEND Therapeutics's top competitors. rEVO Biologics's headquarters is in Framingham, Massachusetts, and was founded in 06/1993. Like ASCEND Therapeutics, rEVO Biologics also works within the Pharmaceuticals industry. rEVO Biologics generates 236% of ASCEND Therapeutics's revenue.
ASCEND Therapeutics VS Duchesnay Inc.
Duchesnay Inc. is one of ASCEND Therapeutics's top rivals. Duchesnay Inc. was founded in 1970, and its headquarters is in Bryn Mawr, Pennsylvania. Like ASCEND Therapeutics, Duchesnay Inc. also works within the Pharmaceuticals field. Duchesnay Inc. has 50 more employees than ASCEND Therapeutics.
ASCEND Therapeutics VS Carwin Pharmaceutical Associates
Carwin Pharmaceutical Associates is ASCEND Therapeutics's #3 rival. Carwin Pharmaceutical Associates is a Private company that was founded in undefined in Hazlet, New Jersey. Like ASCEND Therapeutics, Carwin Pharmaceutical Associates also competes in the Pharmaceuticals sector. Compared to ASCEND Therapeutics, Carwin Pharmaceutical Associates has NaN fewer employees.
Looking for similar companies to ASCEND Therapeutics?
Similar Companies
Pharmaceuticals companies in Morristown
See 16 companies
Companies in Morristown with revenue in $5.0-25M rangeSee 564 companies
Pharmaceuticals & Biotechnology companies in MorristownSee 21 companies
Companies in Morristown with employees in 25-100 rangeSee 697 companies
Pharmaceuticals companies in New JerseySee 708 companies
Pharmaceuticals companies in New York Metropolitan AreaSee 1,035 companies
Pharmaceuticals & Biotechnology companies in New JerseySee 1,085 companies
Pharmaceuticals & Biotechnology companies in New York Metropolitan AreaSee 1,762 companies
Pharmaceuticals companies with revenue in $5.0-25M rangeSee 2,473 companies
Trending News for ASCEND Therapeutics and ASCEND Therapeutics's Competitors
SOUL trial shows Rybelsus significantly lowers major cardiovascular events and CKD risk. Novo Nordisk's breakthrough....
EQS-WpÜG: Grifols Biotest Holdings GmbH / Tender Offer Tender Offer / Target company: Biotest AG; Bidder: Grifols Biotest Holdings GmbH 31.03.2025 / 08...
Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL trial finds Rybelsus lowers c...
Novo Nordisk's stocks experienced the sharpest monthly decline since July 2002 due to growing competition and several disappointing trial results. Howe...
Sanofi Korea announced the launch of Praluent Pen 300mg (ingredient: alirocumab) on Tuesday, following its inclusion in the national health insurance r...
Sanofi is boosting its research and development team by hiring GSK's former head of development Chris Corsico, according to an internal company communi...
/CNW/ - A new sub-analysis of the SELECT trial data shows semaglutide 2.4 mg substantially reduces the burden of total cardiovascular events in people ...
The Global Life Attenuated Vaccines Market is estimated to be valued at USD 29.50 Bn in 2025 and is expected to reach USD 63.21 Bn by 2032, exhibiting ...
Frequently Asked Questions about ASCEND Therapeutics
Who are ASCEND Therapeutics's top competitors?
ASCEND Therapeutics's top 3 competitors are rEVO Biologics, Duchesnay Inc., Carwin Pharmaceutical Associates.Who is similar to ASCEND Therapeutics?
rEVO Biologics is the most similar to ASCEND Therapeutics. Duchesnay Inc. and Carwin Pharmaceutical Associates are also similar to ASCEND Therapeutics.
Are ASCEND Therapeutics and rEVO Biologics competitors?
Yes, rEVO Biologics is one of ASCEND Therapeutics’s top competitors.